Abstract
This paper examines the epidemiology of hypertension and management strategies of cardiovascular diseases (CVDs) in paediatric populations in sub-Saharan Africa and other parts of the world in the 21st century. A computerized literature search was carried out using Medline, Evidence-Based Child Health (A Cochrane Review Journal), the Cochrane Library and Cochrane Child Health Field. A manual search in the African Journal for physical, health education, recreation and dance, the South African Journal for Research in Sports, Physical Education and Recreation and a few individuals in the area were requested to send some of their recent unpublished and published reports in the field. High prevalence rates and high odds ratios for high blood pressure (BP) were recorded in children aged 5–17 years. There is a need for health ministries to improve the public health sector so as to close the gap between the rich and the poor. Although personal and parental responsibility remain crucial, it also falls on the government to help control powerful environmental factors that are leading our children to premature ill-health and mortality. Equally, health professionals are increasingly recognized that they have a significant role to play in delivering medical treatment of hypertension in children.
Introduction
Childhood and adolescence are the greatest periods of change throughout the lifetime of an individual.1, 2 During this period, body shape changes, an independent and abstract cognitive process begins, and the adolescent's transition to the social values and roles of adulthood take place.3 Although childhood and adolescence can be marked by new discoveries and opportunities, they can also produce anxiety and turmoil. Biological and hormonal changes, together with a complex of social issues that these children face, often overshadow the development of non-communicable diseases.4 The risk factors for these non-communicable diseases are thought to be dietary (particularly high levels of saturated fats and excess salts), lack of physical activity, obesity, psychosocial stress and smoking, all of which are identified with biological, hormonal and social changes. Furthermore, family history, age, sex, traffic noise, occupational stress, socioeconomic status and social stress are further purported to be risks for the development of arterial hypertension.5
Hypertension is causing a major health hazard today. It appears to contribute to cardiovascular diseases (CVDs) mortality in African Americans both by accelerating the development of coronary atherosclerosis and by inducing more severe left ventricular hypertrophy.6 In the United States of America, CVDs were regarded as the leading causes of death in 2001, as heart diseases accounted for 29.9% of total deaths and cerebrovascular diseases for an additional 6.8%,7 while in South Africa they were among the top ten leading causes of death.8 The epidemiology and management strategies of hypertension and CVDs ought to be revisited to improve the current status. Therefore, this review paper is aimed at examining the description of the frequencies of elevated blood pressure (BP) in children in sub-Saharan countries compared to other countries in the world and the ways to address cardiovascular risk factors in these paediatric populations.
Materials and methods
Literature search
A computerized literature search for peer-reviewed articles was carried out using Medline, Evidence-Based Child Health (A Cochrane Review Journal), the Cochrane Library and Cochrane Child Health Field. A manual search in the African Journal for Physical, Health Education, Recreation and Dance, the South African Journal for Research in Sport, Physical Education and Recreation and a few individuals in the area were requested to send some of their recent unpublished and published reports in the field. Search terms for the identification of the studies were BP, hypertension prevalence and the incidence rate of hypertension. Studies on paediatric hypertension patients, self-reported hospital subjects, dietary intake, pregnancy, maternal tobacco usage, alcohol, malnutrition, birth weight, obesity, dislipidaemia, diabetic and poor BP measurements were excluded.
Normal population studies between the age span of 0–25 years were selected for prevalence/incidence of hypertension. The probability of children having high elevated BP during their lifetime was investigated using the term odds ratio of hypertension. Very few studies recorded the odds ratio in children. Selection for studies in this category was based on study design, which was mostly prospective cohort studies and national studies that included children aged 15 years and above.
Hypertension is as old as human beings. The 21st century is characterized by high industrialization, high economic growth in most parts of the world and global warming,9, 10 with English as the most convenient language used by many people in the world. Only studies published in English from 1 January 2000 to 30 September 2007 were included. A total of 270 studies were found and only 39 studies that met the above-mentioned criteria were used. Selected studies were categorized by the regions (sub-Saharan Africa, Asia, United States, Europe and Latin America).
Hypertension could not be treated in isolation for its management strategies. Therefore, the search of hypertension management strategies was also expanded to the intervention to reduce cardiovascular risk factors in children.
Subjects
The number of children involved in the reviewed studies varied considerably. The largest sample studied consisted of 3923 11 and 1902 children,12 whereas Addo et al.13 and Smith and Rinderknecht14 studied the smallest sample, 67 children aged below 25 years and 156 children aged 5–18 years, respectively.
The measurement of BP in children is known to be difficult, mainly as a result of a large intraindividual variance.15, 16 This is largely because this period is characterized by the growth and maturation process, which affects BP.17, 18, 19, 20 Therefore, the protocol for measuring BP is important so that similar studies could be reviewed to avoid bias in the interpretation and wrong conclusions that could be drawn. In general, in the selected studies, an automated electronic device was used to measure systolic blood pressure (SBP) and diastolic blood pressure (DBP) at an interval of 5 min apart, after the child had been seated for 5 min or longer15, 16 with the cuff that covers at least two-thirds of the upper arm and encircles at least one-half of the left or right upper arm. A few studies reported that well-trained nurses used a mercury sphygmomanometer or a random zero sphygmomanometer with the cuff that covers at least two-thirds of the upper arm and encircles at least one-half of the left or right upper arm to measure blood pressure. SBP was the first Korotkoff sound, whereas DBP was based either on the fourth or fifth Korotkoff sounds.13, 15
In general, hypertension was defined as the occurrence of SBPand DBP levels greater or equal to the 95th percentile of height and sex-adjusted reference levels.15, 16 Al-Sendi et al.21 based their definition of high BP on the recommendation of the WHO Expert Committee on Hypertension Control.22 In their recommendation, hypertension was defined as SBP and/or DBP greater or equal to the 95th percentile for age, and normal BP status was defined as SBP and/or DBP less than 95th percentile for age. Van der Sande et al.23 defined hypertension following the 1993 WHO guidelines as BP greater than 160/95 mm Hg. Frontini et al.24 and Barger and Muldoon25 classified subjects as hypertensive, if they had SBP higher than 140 mm Hg and DBP higher than 90 mm Hg.
Statistical analysis
Descriptive statistics for BP were presented in all selected studies. Generally, logistic regression was used to calculate the age-adjusted odds ratio for hypertension and the 95% confidence interval (CI).21, 22, 23, 24, 26, 27, 28 Maffeis et al.29 performed a multivariate logistic regression analysis with backward stepping of variables and an evaluation of the model using three goodness of fit X2 statistics, whereas Addo et al.13 used both univariate and multivariate regression models to calculate the odds ratio for hypertension. Barger and Muldoon25 used the ordinal regression model, the cumulative odds model to evaluate differences in self-rated health as a function of hypertension status, labelling which further provides an extension of logistic regression for determining the odds ratios.
Results
Table 1 presents the prevalence of hypertension in selected population studies in sub-Saharan Africa and other parts of the world. The prevalence of hypertension in sub-Saharan Africa ranged 0–12.5% for boys and 0–21.5% for girls (Table 1). The highest prevalence rate recorded was 21.5%31 for girls and 12.5% for boys,32 whereas Steyn et al.30 recorded the highest total prevalence rate of 22.3% for both boys and girls in urban South African children. Misra et al.19 recorded the highest (20.0%) prevalence of BP for boys in the Asian region followed by Smith and Rinderknecht14 in the United Staes (13.2%). Europe recorded a prevalence rate of between 2–13.9% for both boys and girls.21, 24, 35
Table 2 presents the odds ratio and 95% CI for the development of hypertension in selected studies in sub-Saharan Africa and other parts of the world. Monyeki et al.26 reported the highest odds ratio (13.7 95%CI 3.6–51.7) for Ellisras rural South African children aged 11–14.4 years, whereas Frontini et al.24 reported an odds ratio of 5.05 95%CI 1.4–14.7 for Bangalusa, LA, USA.
Evidence from different sources suggests that both physician's non-adherence to recommended guidelines36 and patient non-compliance are contributory to the unsuccessful management strategy of hypertension.37 Figure 1 shows the schema for societal level pathways and strategies for prevention of CVDs. The target population included individuals with no knowledge or information of CVDs, individuals with information of CVDs and illiterate and ignorant individuals. All these groups of individuals are affected by hypertension and other risk factors for CVDs, sometimes during their life circle. The onset of these diseases affects mostly the different vital organs of the body including the heart, brain and kidneys, which lead to mortality with the leading cause being heart attack, heart failure, stroke and others. Kaplan39 proposed that the dividing line between normal and high BP should be the level of BP at which the benefits of action exceed the risk and cost of inaction and should be part of the registration information.
Table 3 provides an example of indicators to be included in the hypertension registration information. Registry data offer insights into disease patterns, medication use and resource utilization over time and allow for assessment of adherence to practice guidelines. However, the limitations of registry data include heterogeneous definitions of diagnoses and cohorts, potential selection biases of included institutions, differences in patience care and selective outcome reporting. Analysis of large controlled clinical trial data could offer additional insight into regional management and outcome differences in individuals with hypertension. It is important for the management strategies to cover intervention with a preventative focus on illiterate and ignorant individuals with no information or knowledge of the diseases, whereas the focus strategy for the individual with knowledge or information of the diseases should be focused on the sociopolitical factors (Figure 1). The outcome or success of these pathways will be noted by the modifying influence on psychological factors, with everybody being aware of the knowledge of prevention and access to care (Figure 1).
The relationship between BP values and the risks of cardiovascular mortality and morbidity is consistent and continuous.40 The higher the BP, the greater the chances of myocardial infarction, heart failure, stroke and renal diseases across the entire BP range (Figure 1).41
Table 4 presents the lifestyle modification and clinical considerations to manage CVDs. The lifestyle modification and recommendation starts from birth to adulthood. It is important for individuals with knowledge of the diseases, for individuals without the knowledge, for the illiterate and ignorant individuals to familiarize themselves with the information contained in the table as it provides an entry point for all individuals. For example, from birth up to 3 years, parents should apply the growth charts to monitor the growth of the child and introduce healthy diet and healthy snacks for the children. As the child grows (3–6 years), in addition to applying the growth chart, healthy diet, the BP chart should be introduced. Furthermore, at this stage, the child should be encouraged to lower salt intake and to take part in physical activities. For individuals who are ignorant or illiterate and diagnosed with high BP, they should receive advice on life modification. Lower dose Aspirin (75 ml) is recommended for secondary prevention of ischaemic CVDs and for primary prevention in people aged over 50 years. In the Heart and Estrogen/Progestine Replacement Study, the outcome of the twofold increase was reported in black women who had a higher rate of diabetes, hypertension and hypercholesterolaemia, but who were less likely to receive aspirin or statin drugs and were less likely at follow-up to have optimal BP or low density lipoprotein-cholesterol (LDL-C) control.36
Discussion
Blood pressure is a well-known, modifiable risk factor for CVDs. The dividing line between normal and high BP is based on epidemiological data. A high-prevalence rate of elevated BP was recorded in children aged 5–17 years, with the highest prevalence of 22.3% recorded at age 5 years in sub-Saharan Africa (South Africa) and 10.3% of the sample aged 5–18 years in the United States15 in the 21st century.
The major problem in paediatric hypertension studies is the measurement of BP, given the well-documented intraindividual variance. Rosner et al.45 reported greater than 75% of total variability of DBP, whereas Kemper et al.46 noted that as a result of the low test–retest reproducibility, the prevalence of BP remained high. However, Zinner et al.47 reported that electronic devices are reliable for use in population studies as they minimized observer error. Furthermore, there is a high correlation between BP and growth of stature, weight and sexual maturity.28, 48, 49 Voors et al.50 emphasize the need to define hypertension on several basal BP values as related to body weight and body dimensions rather than by age. Katz et al.51 reported that the variation of BP is closely related to growth and maturation in adolescents and children. In general, the studies cited in this review classified the children as hypertensive based on the the guidelines for hypertension.12, 13, 31, 32, 30, 33, 34, 35 Frontini et al.24 and Barger and Muldoon25 classified children as hypertensive based on the 140/90 mm Hg recommendation of the WHO. It is clear from the cutoff point of these two studies together with the study of van der Sande et al.22 who used 160/95 mm Hg that the situation might be worse than it is reported in their respective area.
Children are an important target group for health intervention. It is increasingly recognized that the occurrence of adult CVDs are influenced by factors operating throughout the life course.52 Increased risk may start in infancy or even before birth and will continue to be influenced by health-related behaviour during adulthood. There is clear evidence, for example, from the Bogalusa Heart Study that cardiovascular risk factors are identifiable in childhood and are predictive of future cardiovascular risk. The level of CVD risk factors track over time and confirm a lifelong burden of cardiovascular risk. Such risk factors are usually found in constellation with obesity and insulin resistance underlying conditions of hypertension, thrombosis and dyslipidaemia among others.53 Furthermore, the constellation of metabolic syndrome variables at low levels in childhood is associated with a lower measure of cardiovascular risk in adulthood.54
Kemper55 has shown that less intake of salt reduces the BP level. The mobile populations are moving to the cities in large numbers and consuming fast food predisposing them to high levels of hypertension. People of African descent have been found to exhibit a strong tendency towards salt sensitivity and hypertension,56 which could be a possible explanation to the high prevalence of hypertension in urban South African children. Furthermore, the excessive use of alcohol is a risk factor for hypertension. In South Africa, people from 15 years to retirement have the highest rate of excessive alcohol use as do those with little or no education.8 However, very little control of the promotion of alcohol sale is continuing worldwide, whereas a national policy regarding the use of salt is long overdue in many regions.
Successful health education is characterized by efforts to increase self efficacy, to promote self reflection, self-awareness and autonomy, to improve decision-making skills and to provide training in personal skills.42, 43, 55 Some of the health benefits that have been demonstrated in the intervention group have included: total reduction of cholesterol; increased high density lipoprotein-cholesterol (HDL-C), reduction in percentage body fat, increased health knowledge (diet, activity and smoking), aerobic power and physical activity outside school, improved diet with decreased fat and saturated fat intake; decreased prevalence of obesity; improved school meals; decreased risk factors for obesity and TV watching time.8, 30 South Africa implemented very strong tobacco control legislation. This resulted in a drop in tobacco consumption in South Africa by 21.6% from 43.6 to 34.2 million kg of tobacco leaf since 1998.58
Disparity in cardiovascular outcomes persists in sub-Saharan Africa compared to other countries in the world because of the inadequacies of the current health-care system and the failure to focus adequate efforts on population most in need. Furthermore, public and private health care in sub-Saharan Africa differ in terms of lower quality of service, lower quality of diagnoses and poor quality of medicine provided. There is a need for health ministries to improve the public health sector so as to reduce the gap between the rich and the poor.
Health-care professionals should identify high-risk patients and set a strict target and offer the potential to exert maximal impact on cardiovascular outcome. Although personal and parental responsibility remain crucial, it also falls on the government to help control powerful environmental factors that are leading our children to premature ill-health and mortality. Equally, health professionals are increasingly recognized for the significant role they played in delivering medical treatment of hypertension in children. Successful treatment requires great understanding of hypertension causes, consequences and the particular style of approach that is required for children and their families.
An unhealthy lifestyle in the population has led to the escalating increase in CVD mortality. Before deciding on any intervention for CVD prevention and control in a population, a few practical issues have to be taken into account. Firstly, the community health workers employed by the government should be available, particularly in rural areas, to educate the illiterate and ignorant people about the dangers posed by these diseases. Secondly, in urban areas, there should be safe walking or cycling trails to encourage physical activity, as most people could read and learn behaviour by imitation. Thirdly, a multifaced health promotion programme directed at the whole population and a well coordinated primary health service for early diagnoses and the management of persons at high risk of developing the CVD could be helpful. Finally, the success of the policy depends on equity, unified and decentralization of a healthy service for the population. Community participation is central to the success of the programme.
There are some limitations to this review. The period from 1 January 2000 to 30 September 2007 could yield a selection bias, as in some studies subjects were studied before the date and were reported only in 2000, as the review process and publication period differ from one journal to another. Although we have gained insight into the epidemiology of hypertension by investigators of different geographical regions, caution must be exercised in using these data as there was heterogeneity in access to care even within the region.57 Furthermore, population genetic studies indicate tremendous heterogeneity, even within a particular geographic region, as such non-modifiable and management strategies of hypertension and CVD may be unequally distributed within the region, leading to population stratification and confounding even within a seemingly homogeneous group.42
We do have a powerful strength; however, as this review included prospective cohort studies24, 33, 55 and some national studies,12, 23, 25 the data were subject to less bias from recall and old measurements and may thus elucidate a true cause-and-effect association. In addition, BP was measured during early childhood, demonstrating that proper monitoring should be started from a child's early days from a viewpoint of screening for vulnerable individuals.

References
Spear BA . Adolescence growth and development. J Am Diet Assoc 2002; 102: S23–S29.
Cameron N . African obesity: a puzzle solved. SAMJ 1997; 87: 1396–1397.
Heald FP . Adolescence Nutrition. Med Clin North Am 1975; 59: 1329–1336.
Bojorntor P . Regional obesity. In: Bjortorp P, Brodoff BN (eds). Obesity. Lippincot: Philladelphia, 1992, pp 579–586.
Schmieder RE, Messerli FH, Ruddel H . Risk for arterial hypertension. Clin Cardiol 1986; 4: 57–66.
Watkins LO . Epidemiology and burden of cardiovascular disease. Clin Cardiol 2004; 27: III-2.
Arias E, Anderson RN, Hsiang-Ching K, Murphy SL, Kochanek KD . Death: Final data for 2001, National Vital Statistics Report, 52 No 3. National Centre for Health Statistics: Hyattsville Maryland, 2003, pp 27–87.
Bradshaw D, Steyn K . Poverty and chronic disease in South Africa: Technical Report. Medical Research Council: Cape Town, 2001, pp 17–68.
Arthington AH, Bunn SE, Poff NL, Naiman RJ . The challenge of providing environmental flow rules to sudden river ecosystems. Ecol Appl 2006; 16: 1311–1318.
World Health Organization. WHO guidelines on agricultural practices (GACP) for medicinal plants. World Health Organization: Geneva, Switzerland, 2003, pp 2–57.
Barba G, Troiano E, Russo P, Strazzullo P, Siani A . On behalf of ARCA Project Study Group. Body mass, fat distribution and blood pressure in Southern Italian children: Results of ARCA project. Nutr Meta Cardiovas Dis 2006; 16: 239–248.
Makgae PJ, Monyeki KD, Brits JS, Kemper HCG, Mashita J . Somatotype and blood pressure of rural South African children aged 6–13 years: Ellisras Longitudinal Growth and Health Study. Ann Hum Biol 2007; 34: 240–251.
Addo J, Amoah AGB, Koram K . The changing patterns of hypertension in Ghana: A study of four rural communities in the GA district. Ethn Dis 2006; 16: 895–900.
Smith C, Rinderknecht K . Obesity correlates with increase blood pressures in Urban Native American youth. Am J Hum Biol 2003; 15: 78–90.
National high blood pressure education program (NHBPEP) working group on hypertension control in children and adolescents. Update on the 1987 task force report on high blood pressure in children and adolescents: a working group report from the National High Blood Pressure Education Program. Pediatrics 1996; 98: 649–658.
National High Blood Pressure Education Program Working Group on High Blood Pressure in Children and Adolescents. The fourth report on the diagnosis, evaluation, and treatment of high blood pressure in children and adolescents. Pediatrics 2004; 114: 555–576.
Schmieder RE, Messerli FH . Environmental factors as a risk for future hypertension. Stress Med 2006; 2: 241–251.
Van Lenthe FJ, Kemper HCG, Twisk JWR . Tracking blood pressure in children and youth. Am J Hum Biol 1994; 6: 389–399.
Misra A, Madhavan M, Vikram NK, Pamdey RM, Dhingra V, Luthra K . Simple anthropometric measures identify fasting hyperinsulinemia and clustering of cardiovascular risk factors in Asian Indian adolescents. Metab Clin Ex 2006; 55: 1569–1573.
Yusuf S, Reddy S, Ounapuu S, Anands S . Global burden of Cardiovascular Disease. Part I: General consideration, the epidemiological transition, risk factors and impact of urbanization. Circulation 2001; 104: 2746–2753.
Al-Sendi AM, Shetty P, Musaiger AO, Myatt M . Relationship between body composition and blood pressure in Bahraini adolescence. Br J Nutr 2003; 90: 837–844.
World Health Organization. WHO Expert Committee on Hypertension control. World Health Organization: Geneva, Switzerland, 1994. www.who.int/acd/avd/trs862.html#table.
Van der Sande MAB, Milligan PJM, Walraven GEL, Dolmans WMV, Newport M, Nyan OA et al. Geographical variation in prevalence of hypertension with the Ghambia. J Hum Hypertens 2001; 15: 733–739.
Frontini MG, Srinivasan SR, Elkasabany A, Berenson G . Awareness of hypertension and dyslipidemia in a semi rural population of young adults: the Bangalusa Heart Study. Prev Med 2003; 36: 398–402.
Barger SD, Muldoon MF . Hypertension labeling was associated with poorer self-rate health in the Third US National Health and Nutrition Examination Survey. J Hum Hypertens 2006; 20: 117–123.
Monyeki KD, Kemper HCG, Twisk JWR, Makgae PJ, Mashita J, Travill A . Longitudinal development and tracking of risk indicators for cardiovascular diseases of rural South African children: Ellisras Longitudinal Growth and Health Study. J Sci 2007 (in press).
Facchini F, Fiori G, Bedogni G, Galletti L, Belcastro MB, Ismagulov O et al. Prevalence of overweight and cardiovascular risk factors in rural and urban children from central Asia: The Kazakhstan Health and Nutritional Examination Survey. Am J Hum Biol 2007; 19: 809–820, 10.102/ajbh.
Israel E, Korzets Z, Tekes-Manova D, Tirosh A, Schochat T, Bernheim J et al. Blood Pressure categories in Adolescence Predict Development of hypertension in accordance with European guidelines. AJH 2007; 20: 705–709.
Maffeis C, Pietrobelli A, Grezzani A, Provera S, Tato L . Waist circumference and Cardiovascular risk factors in pre pubertal children. Obes Res 2001; 9: 179–187.
Steyn K, de Wet T, Richter L, Cameron N, Levitt NS, Morrel C . Cardiovascular diseases risk factors in 5-year old urban South African children- The Birth to Ten Study. SAMJ 2000; 90: 719–726.
Schutte AE, van Rooyen JM, Huisman HW, Kruger HS, Malan NT . The potential role of biotin as dietary risk marker for hypertension in black South African children- the THUSA BANA study. SAJCN 2003; 16: 144–148.
Schutte AE, van Rooyen JM, Huisman HW, Kruger HS, de Ridder JH . Factor analysis of possible risk for hypertension in a black South African population. J Hum Hypertens 2003; 17: 339–348.
Monyeki KD, Kemper HCG, Makgae PJ . The association of fat patterning with blood pressure in rural South African children: the Ellisras Longitudinal Growth and Health Study. Int J Epidemiol 2006; 35: 114–120.
Moore WE, Stephens A, Wilson T, Wilson W, Eichner JE . Body mass index and blood pressure screening in a rural public school system: the Health Kids Projects. Prev Chr Dis Pub Healt R, Pract and Policy 2006; 3: 1–10.
Agirbasli M, Tanrikulu B, Arikan S, Izci E, Ozguven S, Besimoglu B et al. Trends in body mass index, blood pressure and parental smoking habits in middle socio-economic level Turkish adolescents. J Hum Hypertens 2007; 22: 1–6.
O'Connor PJ . Overcome clinical linarite to control systolic blood pressure. Arch Intern Med 2003; 163: 2677–2678.
Jones MA, Schlenk EA, Kitutu JM, Sereika SM, Doswell WM, Dunbar-Jacob J . Ethnic differences in the adherence to antihypertensive medications: A prospective study (abstract). Circulation 2003; 108: IV-381.
Ben-Shlomo Y, Kuh D . A life course approach to chronic diseases epidemiology: conceptual models, empirical challenges and interdisciplinary perspectives. Int J Epidemiol 2002; 31: 285–293.
Kaplan NM . Hypertension: Prevalence, risks and effect of therapy. Ann Intern Med 1983; 98: 705–709.
Chobanian AV, Bakris GL, Black HR, Cushman WC, Green LA, Izzo Jr JL et al. Joint national committee on prevention detection evaluation and treatment of high blood pressure: National Heart, lung and blood Institute: National High Blood Pressure program Coordinating Committee, Seventh report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure. Hypertension 2003; 42: 1206–1252.
Lewington S, Clarke R, Qizilbash N, Peto R, Collins R . Age specific relevance of usual blood pressure to vascular mortality: a meta analysis of individual data for one million adults in 61 prospective studies. Lancet 2002; 360: 1903–1913.
Washington R . Intervention to reduce cardiovascular risk factors in children and adolescents. Am Fam Physician 1999; 59: 2211–2219.
Williams B, Poulter NR, Brown MJ, McInnes GT, Potter JF, Sever PS et al. Education and debate. British hypertension Society guidelines for hypertension management 2004 (BHS-IV): Summary. BMJ 2004; 328: 634–640.
Lemogoum D, Seedat YK, Mabadeje FB, Mendis S, Bovet P, Onwubere B et al. Recommendation for prevention, diagnosis and management of hypertension and cardiovascular risk factors in Sub-Saharan Africa. J Hypertens 2003; 21: 1993–2000.
Rosner B, Cook NR, Evan DA, Keough ME, Taylor JO, Polk BF et al. Reproducibility and predictive values of routine blood pressure measurements in children. Comparison with adult values and implications for screening children for elevated blood pressure. Am J Epidemiol 1987; 126: 1115–1125.
Kemper HCG, Snel J, Verschuur R, Storm van Essen L . Tracking of health and risk indicators of cardiovascular diseases from teenager to adulthood: The Amsterdam Growth and Health Study. Prev Med 1991; 19: 642–655.
Zinner SH, Martins LF, Sacks F, Rosner B, Kass EH . A longitudinal study of blood pressure in childhood. Am J Epidemiol 1974; 100: 437–442.
Shasha SM, Cohe-Tal I, Epstein L, Tamir A . Tracking of blood pressure in children: results of 7 years follow-up. The Nahariya Study. Isr J Med Sci 1988; 24: 671–675.
Weir MR, Stafford EM, Gregory G, Lawson MA, Peal W . The relationship between sexual maturity rating, age and increased blood pressure in adolescent. J Adoles Health Care 1988; 9: 465–469.
Voors AW, Webber LS, Berenson GS . Time course study of blood pressure in children over a three-year period. Bagalusa Heart Study. Hypertension 1980; 2: 102–108.
Katz SH, Hediger ML, Schall JI, Bowers EJ, Barker WF . Blood pressure, growth and maturation from childhood through adolescent. Hypertension 1980; 2: I-55–I-69.
Kuh DJL, Ben Schlomo Y . A life course approach to chronic disease epidemiology. Oxford University press: Oxford, 2004, pp 23–72.
Chen W, Srinivasan SR, Li S, Xu J, Berenson GS . Metabolic syndrome variables at low levels in childhood are beneficial associated with adulthood cardiovascular risk: the Bangalusa heart study. Diabetes Care 2005; 1: 125–126.
Berenson GS, Srnivasan SR . Cardiovascular risk factor in youth with implications for aging: the Bogalusa Heart Study. Neurobiol Aging 2005; 26: 303–307.
Kemper HCG . Amsterdam growth and Health longitudinal study: A 23 year follow up from teenager to adult about lifestyle and health. Karger: New York, 2004, pp 1–20.
Graudal NA, Galloe AM, Garred P . Effects of sodium restriction on blood pressure, rennin, adolescent, catecholamine's, cholesterols and triglyceride: a meta analysis. JAMA 1998; 279: 1383–1391.
Ryden L, Stokoe G, Breithardt G, Lindemans F, Potgieters A . Patience access to Medical technology across Europe. Eur Heart J 2004; 25: 611–616.
Republic of South Africa Tobacco Board. Annual Report. Government Printer: Pretoria, 1998, pp 119–130.
Acknowledgements
Dr Taryn Young, Cochrane Library, Medical Research Council is thankfully acknowledged for the advice and valuable information she provided in the preparation of this manuscript. The authors are grateful to Tania Witbooi, Chronic Diseases of Lifestyle Unit, Medical Research Council and Titus Motlogeloa, Johanna Makgae and Thomas Makata, Ellisras Longitudinal Growth and Health Study administrators and to the South African Medical Research Council for providing technical support in the preparation of this manuscript. Monyeki MS and Malatji MJ (Makgoka High School, Limpopo Province) are thankfully acknowledged for editing this manuscript.
Author information
Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Monyeki, K., Kemper, H. The risk factors for elevated blood pressure and how to address cardiovascular risk factors: a review in paediatric populations. J Hum Hypertens 22, 450–459 (2008). https://doi.org/10.1038/jhh.2008.21
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1038/jhh.2008.21
Keywords
- cardiovascular diseases
- children
- sub-Saharan Africa
Further reading
-
Elevated Blood Pressure and Associations with Sodium Intake Among Multiethnic Youth in Edmonton, Canada: Findings from WHY ACT NOW
High Blood Pressure & Cardiovascular Prevention (2020)
-
The relationship between sitting height, sitting height to height ratio with blood pressure among Polokwane private school children aged 6–13 years
BMC Public Health (2017)
-
Performance of blood pressure to height ratio as a screening tool for elevated blood pressure in rural children: Ellisras Longitudinal Study
Journal of Human Hypertension (2017)
-
Body mass index, cardiorespiratory fitness and cardiometabolic risk factors in youth from Portugal and Mozambique
International Journal of Obesity (2015)
-
Blood pressure in primary school children in Uganda: a cross-sectional survey
BMC Public Health (2014)
